ThromboGenics up on first trading day

ThromboGenics (Euronext:THR) gained EUR 0.14 to EUR 4.64 in its first day of trading. On Thursday, THR raised EUR 35 million ($44.8 million) in an IPO through the sale of 7.8 million shares at EUR 4.5...